M3, Inc.(2413) Summary
2413
TSE Prime
M3, Inc.
Result
1,610.0
JPY
-4.5
(-0.28%)
Jun 12, 3:30 pm JST
10.04
USD
Jun 12, 2:30 am EDT
PER
20.2
PBR
2.63
Yield
ー%
Margin Trading Ratio
22.65
PTS
outside of trading hours
1,612.5
Jun 12, 10:52 pm JST
Stock Price
Jun 12, 2026
Opening
Jun 12, 9:00 am
1,608.5
JPY
10.04
USD
Previous Close
Jun 11
1,614.5
JPY
10.05
USD
High
Jun 12, 9:36 am
1,621.5
JPY
10.12
USD
Low
Jun 12, 9:00 am
1,590.0
JPY
9.92
USD
Volume
4,622,400
Trading Value
7.44B
JPY
0.05B
USD
VWAP
1608.63
JPY
10.04
USD
Minimum Trading Value
161,000
JPY
1,004
USD
Market Capitalization
1.09T
JPY
6.83B
USD
Number of Trades
7,317
Opening
Jun 12, 8:13 pm
1,602.5
JPY
Previous Close
Jun 12
1,610.4
JPY
High
Jun 12, 10:37 pm
1,620
JPY
Low
Jun 12, 8:13 pm
1,602.5
JPY
Volume
500
Trading Value
0.80M
JPY
VWAP
1,612.00
JPY
Minimum Trading Value
ー
Market Capitalization
ー
Number of Trades
ー
PTS Stock Price
Liquidity & Number of Trades
As of Jun 12, 2026
Liquidity
Liquidity Grade
| Liquidity | Number Of Trades | Distribution |
|---|---|---|
| High | Over 1,000 | 13.9% |
| Slightly-High | 400 to 1,000 | 18.5% |
| Mid | 50 to 400 | 39.0% |
| Slightly-Low | 10 to 50 | 17.6% |
| Low | Less than 10 | 11.0% |
High
1-Year Average
7,840
1-Year High
Aug 7, 2025
48,319
Margin Trading
| Date | Short Interest | Long Margin Positions | Ratio |
|---|---|---|---|
| Jun 5, 2026 | 224,800 | 5,091,000 | 22.65 |
| May 29, 2026 | 223,600 | 5,509,900 | 24.64 |
| May 22, 2026 | 202,800 | 5,772,800 | 28.47 |
| May 15, 2026 | 272,400 | 6,517,000 | 23.92 |
| May 1, 2026 | 214,600 | 5,545,700 | 25.84 |
Company Profile
M3, Inc. is a Sony Group affiliate specializing in pharmaceutical marketing support. It provides information through a website for physicians and is also involved in telemedicine.
Sector
Services
Website
M3, Inc., a member of the Sony Group, aims to revolutionize the medical world through the use of the internet. The company operates various services both domestically and internationally, centered around its professional medical website "m3.com". Its main business activities include marketing support for medical-related companies, surveys targeting healthcare professionals, practice management services, clinical trial support, CSO operations, and the development and sale of electronic medical records. M3 also engages in evidence solution services such as clinical development support, clinical trial management and operational support, and subject recruitment assistance. Additionally, the company provides human resource services for medical professionals, management support for medical institutions, and operates hospice facilities. Internationally, M3 has expanded its operations globally, offering marketing support, surveys, human resource services for medical professionals, and clinical trial support.